Skip to content
Lower risk Medical device recall · FDA · Published November 2, 2017

Epigenomics Epi proColon Plasma Quick Kit: Invalid Test Results Risk

Epigenomics recalls Epi proColon Plasma Quick Kit (M5-02-001) due to potential invalid test results. This may delay diagnostic results. No remedy specified in recall notice.

🇺🇸 FDA recall #Z-1077-2018Medical deviceEpigenomics ›
Take action

Contact the company

Recalling firmEpigenomics AgGeneststr. 5 · Berlin, Germany
✎ GovInfoNow plain-language explainer

What happened, in plain English

Epigenomics is recalling its Epi proColon Plasma Quick Kit (catalog M5-02-001) because it may produce invalid test runs, which could delay diagnostic results. This affects users who rely on this kit for testing. Read more at govinfonow.com/recall/72634-epigenomics-epi-procolon-plasma-quick-kit-invalid-test-results-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/72634-epigenomics-epi-procolon-plasma-quick-kit-invalid-test-results-risk · Updated September 14, 2026 · FDA enforcement record: FDA #Z-1077-2018

Cite this page

“Epigenomics Epi proColon Plasma Quick Kit: Invalid Test Results Risk.” GovInfoNow, updated September 14, 2026. https://govinfonow.com/recall/72634-epigenomics-epi-procolon-plasma-quick-kit-invalid-test-results-risk. Based on FDA recall #Z-1077-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1077-2018%22&limit=1).

Why it’s dangerous

The kit may produce invalid test runs, which can delay diagnostic results. This happens because the test kit might not work correctly, leading to inaccurate or no results.

Who’s affected

Users of the Epi proColon Plasma Quick Kit for diagnostic testing are affected. Those who have the kit and use it for medical testing are most at risk of delayed results.

How to tell if you have this one

Check for the catalog number M5-02-001 on the kit. The kit includes 1x Lysis Binding Buffer, 1x Wash B Concentrate, 1x Dilution Buffer, 4x Bisulfate Solution, and 1x Protection Buffer.

  • Brand
    Epigenomics
  • Product
    Epi proColon Plasma Quick Kit; Catalog Number: M5-02-001: Consists of 1x Lysis Binding Buffer, 1x Wash B Concentrate
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Details

    Look for the catalog number M5-02-001 on the kit to confirm it is recalled.

Where it went and when

Where it was distributed

Distributed in 10 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: yesMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: yesPANew Jersey: yesNJConnecticut: not listedCTCalifornia: yesCAUtah: yesUTColorado: not listedCONebraska: yesNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “Shipped to one U.S. distributor in NY. Further distributed in 9 states: CA, MI, NC, NE, NJ, PA, TN, TX, UT.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Michigan, Nebraska, New Jersey, New York, North Carolina, Pennsylvania, Tennessee, Texas, Utah.

Recall timeline

FDA terminated this recall 8 months after the firm started it.

1. Firm started the recall: Nov 2, 201712. FDA classified it Class II: Mar 16, 201823. Published in FDA’s Enforcement Report: Mar 28, 201834. FDA terminated the recall: Jun 19, 2018420172018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1077-2018 (November 2, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1077-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on September 14, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA